Serum interleukin-6 levels in breast carcinoma: Association with histological grade and clinicopathological parameters in a tertiary care centre in North-East India

Background : The course of breast cancer is influenced by tumour-associated inflammatory mediators. The pleiotropic pro-inflammatory cytokine interleukin-6 (IL-6) has been associated with angiogenesis, invasion, metastasis, epithelial-mesenchymal transition and tumour proliferation. Methods : This prospective observational study was carried out in the Department of Pathology, Silchar Medical College & Hospital, Assam, from October 2023 to September 2024. Fifty adult women with newly diagnosed, histopathologically confirmed breast carcinoma were enrolled. Pre-treatment serum IL-6 levels were determined by quantitative sandwich enzyme-linked immunosorbent assay. Tumours were staged according to the AJCC TNM classification and graded using the modified Bloom-Richardson grading system. Results : The mean tumour size was 4.066 ± 1.9858 cm. Serum IL-6 levels increased progressively with histological grade: 29.537 pg/mL in Grade I, 76.153 pg/mL in Grade II and 151.060 pg/mL in Grade III tumours (p < 0.001). A significant positive correlation was observed between serum IL-6 level and tumour size (r = 0.333, p = 0.018). In TNM subgroup analysis, serum IL-6 levels were higher in advanced disease, suggesting an association between increasing tumour stage and inflammatory activity. Conclusion : Serum IL-6 levels were significantly associated with higher histological grade and showed a significant positive correlation with tumour size in breast cancer. These findings support the potential role of serum IL-6 as an additional marker of tumour aggressiveness. Larger multicentric studies with uniform statistical reporting and longer follow-up are required before widespread prognostic application.

Authors

Institutions

Publication Details

Journal
Indian Journal of Pathology and Oncology
Published
2026-11-16
DOI
https://doi.org/10.18231/j.ijpo.18272.1793255615
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Serum interleukin-6 levels in breast carcinoma: Association with histological grade and clinicopathological parameters in a tertiary care centre in North-East India

Nargis Ahmed, Nivedita Dasgupta, Momota Naiding, Shubarna Chakraborty et al.
Indian Journal of Pathology and Oncology
Breast Cancer Treatment Studies
article

Serum interleukin-6 levels in breast carcinoma: Association with histological grade and clinicopathological parameters in a tertiary care centre in North-East India

Nargis Ahmed, Nivedita Dasgupta, Momota Naiding, Shubarna Chakraborty, Rajib Biswas
article en

Abstract

Background : The course of breast cancer is influenced by tumour-associated inflammatory mediators. The pleiotropic pro-inflammatory cytokine interleukin-6 (IL-6) has been associated with angiogenesis, invasion, metastasis, epithelial-mesenchymal transition and tumour proliferation. Methods : This prospective observational study was carried out in the Department of Pathology, Silchar Medical College & Hospital, Assam, from October 2023 to September 2024. Fifty adult women with newly diagnosed, histopathologically confirmed breast carcinoma were enrolled. Pre-treatment serum IL-6 levels were determined by quantitative sandwich enzyme-linked immunosorbent assay. Tumours were staged according to the AJCC TNM classification and graded using the modified Bloom-Richardson grading system. Results : The mean tumour size was 4.066 ± 1.9858 cm. Serum IL-6 levels increased progressively with histological grade: 29.537 pg/mL in Grade I, 76.153 pg/mL in Grade II and 151.060 pg/mL in Grade III tumours (p < 0.001). A significant positive correlation was observed between serum IL-6 level and tumour size (r = 0.333, p = 0.018). In TNM subgroup analysis, serum IL-6 levels were higher in advanced disease, suggesting an association between increasing tumour stage and inflammatory activity. Conclusion : Serum IL-6 levels were significantly associated with higher histological grade and showed a significant positive correlation with tumour size in breast cancer. These findings support the potential role of serum IL-6 as an additional marker of tumour aggressiveness. Larger multicentric studies with uniform statistical reporting and longer follow-up are required before widespread prognostic application.

Indian Journal of Pathology and OncologyVol. 13(4)
Silchar Medical College and Hospital (IN)
Good health and well-being
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon